Regulatory Landmines in Health Care Litigation: PHI, Kickback, and Corporate Structure Risks [Video]
In this episode of Speaking of Litigation®, Epstein Becker Green attorneys Jonathan Brollier, Charles E. Weir, and Megan Thibert-Ind discuss regulatory and business issues unique to the health care industry that can affect how cases are litigated and resolved.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | ITAR Brokering in Foreign Defense Transactions: DS–4294 Approval, Expanding Enforcement, and Hidden Liability Risks | 0 | 17.14 | 06-10-2026 |
| 2 | Prosecutorial Guidance and Non-Prosecution Policies: A Pragmatic Path Forward for AI in Legal Services | 0 | 17.14 | 18-09-2026 |
| 3 | From State Regulation to Federal Rescheduling: Lessons Learned and the Road Ahead | 0 | 10 | 07-10-2026 |
| 4 | Employee Misconduct: Burden-Shifting Returns with NLRB’s Latest Lion Elastomers | 0 | 21.11 | 07-10-2026 |
| 5 | Baker McKenzie Lawyers Discuss Global Dealmaking Risks as MFN Drug Pricing Policy Reshapes Pharmaceutical Transactions | 0 | 10 | 18-09-2026 |
| 6 | United States: Legal Accountability for AI Agents | 0 | 10 | 01-07-2026 |
| 7 | The (Still) Toothless Nondelegation Doctrine and the Trouble with Second-Best Nondelegation Strategies: FCC v. Consumers’ Research | 0 | 13.13 | 11-09-2026 |
| 8 | United States: Uninsurable Positions - Lessons from Kadau v. Commissioner | 0 | 10 | 04-08-2026 |
| 9 | Графика. Чем опасны ИИ-лекари | 0 | 35 | 06-10-2026 |